A systematic review to assess adherence and persistence with statins
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To identify and assess studies published over a 10 year period up to February 2016 which measure adherence or persistence with statins, to summarize their methods, strengths and weaknesses and to summarize evidence linking statin adherence/persistence with risk of cardiovascular events. METHODS: Electronic databases and abstracts from four major cardiovascular disease conferences were searched from January 2005 to February 2016. The study selection process was performed by two reviewers working independently. Studies were included if they reported data regarding patient adherence or persistence with statins in adults with primary hypercholesterolemia, using any type of study design or length of follow-up. One reviewer extracted the study data and assessed study quality, which was checked by a second reviewer independently. Given the heterogeneity between the included studies a narrative critique and summary is presented. RESULTS: We report on 84 real world studies which aimed to assess adherence or persistence with statins. The majority of studies concluded that good adherence/persistence was associated with reduction in cardiovascular events and mortality. In two studies high intensity statin regimens were associated with poorer patient adherence when compared to low intensity statins. Adherence and persistence with statin therapy also has an impact on hospitalization costs and other cardiovascular disease (CVD) related costs. CONCLUSIONS: Adherence and persistence are associated with a reduction in CVD events and mortality. There was limited evidence to suggest that high intensity statin regimens are associated with poorer treatment adherence when compared to lower intensity regimens. Hence, more robust studies are required to establish this association. As recommended by the 2013 ACC/AHA, 2016 ESC and several other clinical guidelines, clinicians and pharmacy managers should regularly monitor statin therapy adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 2×
“Location North America 71 (47) Europe 53 (35) Other 10 (7) Worldwide 7 (5)”
BackgroundMethodImpact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Parris, E. S., Lawrence, D. B., Mohn, L. A., & Long, L. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.595 · Cited by 155
Chodick, G., Shalev, V., Gerber, Y., Heymann, A. D., Silber, H., Simah, V., & Kokia, E. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.11.012 · Cited by 145
Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.052 · Cited by 123
Discontinuation of statin therapy due to muscular side effects: A survey in real life
Rosenbaum, D., Dallongeville, J., Sabouret, P., & Bruckert, E. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.04.012 · Cited by 111
Cited by
ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
De Geest, S., Zullig, L. L., Dunbar-Jacob, J., Helmy, R., Hughes, D. A., Wilson, I. B., & Vrijens, B. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0543 · Cited by 360
“(1-4) For many conditions, taking medications as prescribed is crucial to 49 achieve optimal outcomes.(5-7) Despite more than 50 years of research, the evidence base for 50 effective interventions that can be implemented in routine clinical care remains limited.”
BackgroundAn overview of the common methods used to measure treatment adherence
Anghel, L. A., Farcas, A. M., & Oprean, R. N. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1201 · Cited by 335
“This has been repeatedly demonstrated for a number of chronic conditions: asthma, diabetes, tuberculosis, cardiovascular disorders, HIV, mental disorders, rheumatic conditions [1-8].”
BackgroundOkamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Forbes, C. A., Deshpande, S., Sorio-Vilela, F., Kutikova, L., Duffy, S., Gouni-Berthold, I., & Hagström, E. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1477747 · Cited by 149
Self-citationFlint, A. C., Conell, C., Ren, X., Kamel, H., Chan, S. L., Rao, V. A., & Johnston, S. C. (2017) · Stroke · doi:10.1161/strokeaha.117.017343 · Cited by 56
Metadata
- Authors
- Deshpande, S., Quek, R. G. W., Forbes, C. A., de Kock, S., Kleijnen, J., Gandra, S. R., & Simpson, R. J.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2017-01-20
- Volume
- 33
- Issue
- 4
- Pages
- 769-778
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2577863950
- Cited by
- 90
- References
- 8
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review to assess adherence and persistence with statins. https://app.cochat.ai/papers/10.1080/03007995.2017.1281109
- The paper
- Deshpande, S., Quek, R. G. W., Forbes, C. A., de Kock, S., Kleijnen, J., Gandra, S. R., & Simpson, R. J. (2017). A systematic review to assess adherence and persistence with statins. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2017.1281109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.